3 results
8-K
EX-99.1
TYRA
Tyra Biosciences Inc
7 Nov 23
Tyra Biosciences Reports Third Quarter 2023 Financial Results and Highlights
4:07pm
and early November 2023, TYRA presented additional preclinical results on TYRA-300 in achondroplasia at the American Society for Bone and Mineral Research … (ASBMR) and the American Society of Human Genetics (ASHG) 2023 annual meetings, respectively. In preclinical mice models of achondroplasia conducted
8-K
EX-99.1
TYRA
Tyra Biosciences Inc
3 Nov 22
Tyra Biosciences Reports Third Quarter 2022 Financial Results and Highlights
4:16pm
-tumor activity and selectivity of TYRA-300 as compared to other agents in the class in a poster presentation at the European Society for Medical
- Prev
- 1
- Next